REGENERON PHARMACEUTICALS, INC. EPS (Diluted) 2010-2025 | REGN
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is REGENERON PHARMACEUTICALS, INC.'s current eps (diluted)?
REGENERON PHARMACEUTICALS, INC. (REGN) annual eps (diluted) for 2025 was $41.48, a 8.19% increase from 2024. REGENERON PHARMACEUTICALS, INC. eps (diluted) for the quarter ending September 30, 2025 was $13.62.
What was REGENERON PHARMACEUTICALS, INC.'s eps (diluted) in 2024?
REGENERON PHARMACEUTICALS, INC. annual eps (diluted) for 2024 was $38.34, a 10.27% increase from 2023.
What was REGENERON PHARMACEUTICALS, INC.'s eps (diluted) in 2023?
REGENERON PHARMACEUTICALS, INC. annual eps (diluted) for 2023 was $34.77, a 9.03% decline from 2022.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year eps (diluted) CAGR?
REGENERON PHARMACEUTICALS, INC. eps (diluted) grew at a compound annual growth rate (CAGR) of 6.33% from FY2020 to FY2025, going from $30.52 to $41.48 over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $41.48 | +8.2% | 10-K |
| FY2024 | $38.34 | +10.3% | 10-K |
| FY2023 | $34.77 | -9.0% | 10-K |
| FY2022 | $38.22 | -46.9% | 10-K |
| FY2021 | $71.97 | +135.8% | 10-K |
| FY2020 | $30.52 | +65.3% | 10-K |
| FY2019 | $18.46 | -13.3% | 10-K |
| FY2018 | $21.29 | +105.9% | 10-K |
| FY2017 | $10.34 | +34.3% | 10-K |
| FY2016 | $7.70 | +39.5% | 10-K |
| FY2015 | $5.52 | +85.2% | 10-K |
| FY2014 | $2.98 | -19.9% | 10-K |
| FY2013 | $3.72 | -44.9% | 10-K |
| FY2012 | $6.75 | +375.5% | 10-K |
| FY2011 | $-2.45 | -94.4% | 10-K |
| FY2010 | $-1.26 | - | 10-K |